SCHEMBL659501

SCHEMBL659501

CCNc1nc2cccc(Br)c2s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.54
NPC1 O15118 6/20 0.39
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
ALDH1A1 P00352 4/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
SHMT2 P34897 1/20 0.37
RAB9A P51151 5/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
CRHR1 P34998 1/20 0.36
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658937 0.81 APP (0.40) POLBNPC1CCNA2CDK2ALDH1A1
SCHEMBL1619976 0.74 MEN1 (0.63) POLBNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL1913774 0.74 NPC1 (0.61) POLBNPC1ALDH1A1LMNAMAPT
SCHEMBL25156042 0.73 RAB9A (0.42) NPC1CDK2ALDH1A1MAPTRAB9A
SCHEMBL19792455 0.72 POLB (0.49) POLBNPC1CCNA2CDK2ALDH1A1
SCHEMBL34472184 0.72 NPC1 (0.52) NPC1ALDH1A1LMNAMAPTRAB9A
SCHEMBL658947 0.71 POLB (0.48) POLBNPC1CCNA2CDK2ALDH1A1
SCHEMBL1619718 0.69 ASH1L (0.44) NPC1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL660041 0.69 PSMB8 (0.40) CDK2ALDH1A1HSP90AA1HSP90AB1KMT2A
SCHEMBL663501 0.69 BACE1 (0.36) HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 POLB 4297/4885NPC1 976/4885CCNA2 2362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.